Scarborough, ME, United States of America

Jill L Kerrick




Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jill L. Kerrick

Introduction

Jill L. Kerrick is a notable inventor based in Scarborough, ME (US). She has made significant contributions to the field of immunology, particularly in the detection of mycobacterial infections. With a total of 3 patents to her name, her work has the potential to impact diagnostic methods in healthcare.

Latest Patents

Kerrick's latest patents include a method for preparing enriched antibodies specifically designed for detecting mycobacterial infections. The disclosed technology provides an enriched antibody population that is highly specific for an antigen of a surface polysaccharide from a mycobacterium. In a related embodiment, the antibody is enriched by being raised in an environment that maintains antigenically active antigen. These antibodies can be utilized in an immunoreactive environment to detect the presence of a mycobacterial infection in samples from subjects. Another patent focuses on enriched antibodies for detecting mycobacterial infections, detailing methods of use and diagnostic tests employing the same technology.

Career Highlights

Kerrick is currently associated with Chemogen, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving diagnostic techniques and enhancing the understanding of mycobacterial infections.

Collaborations

Throughout her career, Jill has collaborated with esteemed colleagues, including Vladimir Andrei Koulchin and Elena Valentin Molokova. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jill L. Kerrick's contributions to the field of immunology through her patents and collaborative efforts highlight her dedication to advancing medical diagnostics. Her work not only enhances our understanding of mycobacterial infections but also paves the way for improved healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…